2-hydroxy-dATP diphosphatase

From WikiMD.com Medical Encyclopedia

2-hydroxy-dATP diphosphatase[edit | edit source]

MTH1 hydrolyzing oxidized nucleotide
MTH1 recognizing oxidized nucleotides

2-hydroxy-dATP diphosphatase, also known as MTH1, is an enzyme that plays a crucial role in maintaining the integrity of the nucleotide pool by hydrolyzing oxidized nucleotides. This enzyme is part of the nudix hydrolase family and is responsible for preventing the incorporation of damaged nucleotides into DNA, which can lead to mutations and genomic instability.

Function[edit | edit source]

The primary function of 2-hydroxy-dATP diphosphatase is to sanitize the nucleotide pool by hydrolyzing oxidized forms of deoxyribonucleoside triphosphates (dNTPs), such as 2-hydroxy-dATP. These oxidized nucleotides can arise from oxidative stress and, if incorporated into DNA, can cause transversion mutations. MTH1 specifically hydrolyzes these oxidized nucleotides to their corresponding monophosphates, thus preventing their incorporation into DNA.

Mechanism[edit | edit source]

MTH1 recognizes and binds to oxidized nucleotides through its active site, which is highly specific for damaged dNTPs. The enzyme catalyzes the hydrolysis of the pyrophosphate bond, converting the triphosphate form into a monophosphate and releasing inorganic pyrophosphate. This reaction is crucial for maintaining the fidelity of DNA replication and repair processes.

Biological significance[edit | edit source]

The activity of 2-hydroxy-dATP diphosphatase is essential for protecting cells from the deleterious effects of oxidative damage. By preventing the incorporation of oxidized nucleotides into DNA, MTH1 helps to maintain genomic stability and prevent mutations that could lead to cancer and other diseases. The enzyme is particularly important in cells exposed to high levels of oxidative stress, such as neurons and cancer cells.

Clinical relevance[edit | edit source]

Given its role in preventing DNA damage, MTH1 has been studied as a potential target for cancer therapy. Inhibitors of MTH1 have been developed with the aim of increasing the level of oxidative damage in cancer cells, thereby promoting cell death. However, the therapeutic potential of MTH1 inhibitors is still under investigation.

Related pages[edit | edit source]

Gallery[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD